For example, combining anti-CD3 and anti-epidermal growth factor receptor (EGFR) antibodies with the PDGFR region on EV membranes can simultaneously target T cells and EGFR-expressing triple-negative breast cancer cells[90]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.